B. Gigante et al., Role of the angiotensin II AT(2)-subtype receptors in the blood pressure-lowering effect of losartan in salt-restricted rats, J HYPERTENS, 16(12), 1998, pp. 2039-2043
Citations number
29
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Objective The aim of this study was to evaluate the potential role of the a
ngiotensin II (Ang II) AT(2) receptors (AT(2)) in the control of blood pres
sure (BP) in the rat and the effects of AT(2) receptors on BP during AT(1)
receptor (AT(1)) antagonism.
Methods The study was performed in 52 Sprague-Dawley rats, which were preli
minarily salt-restricted (SR) to enhance circulating and tissue renin-angio
tensin system activity. To explore whether AT(2) plays a role in BP regulat
ion, the BP effects of the selective AT(2) end AT(1) receptor antagonists P
D123319 (PD) (50 mu g/kg/min) and losartan (Los) (10 mg/kg/day), were studi
ed. Seven rats were used as a control group. To define whether AT(2) plays
a role in the BP response observed during AT(1) antagonism, 17 Los treated
rats were divided into two groups: seven were treated with both antagonists
(Los + PD) and 10 rats received Los + vehicle. The effects of both drugs w
ere also studied in bilaterally nephrectomized rats (NX). All treatments we
re maintained for 1 week.
Results Los reduced BP significantly in both intact (P < 0.001) and NX (P <
0.05) rats, while PD increased BP in intact and NX rats (both P< 0.001). I
n the Los + PD group BP levels were significantly higher (P < 0.001 vs Los
and Los + vehicle, P = ns vs pretreatment), while vehicle infusion did not
modify the BP response to Los.
Conclusion The results show that in salt-restricted rats AT(2) blockade off
sets the BP-lowering effect of losartan and suggest that AT(2) receptors co
ntribute to the hypotensive effects of losartan. Thus, AT(1) receptor antag
onists such as losartan, which are becoming widely used in the clinical tre
atment of hypertension, may reduce BP not only by blockade of AT(1) recepto
rs, but also through the stimulation of AT(2), receptors by the excess of a
ngiotensin II. J Hypertens 1998, 16:2039-2043 (C) 1998 Lippincott Williams
& Wilkins.